pharmaceutical companies

See the following -

Health Care Costs Traced to Data and Communication Failures

Andy Oram | EMR & EMH | April 12, 2016

Most of us know about the insidious role of health care costs in holding down wages, in the fight by Wisconsin Governor Scott Walker over pensions that tore the country apart, in crippling small businesses, and in narrowing our choice of health care providers. Not all realize, though, that the crisis is leaching through the health care industry as well, causing hospitals to fail, insurers to push costs onto subscribers and abandon the exchanges where low-income people get their insurance, co-ops to close, and governments to throw people off of subsidized care, threatening the very universal coverage that the ACA aimed to achieve. Lessons from a ground-breaking book by T.R. Reid, The Healing of America, suggests that we’re undergoing a painful transition that every country has traversed to achieve a rational health care system...

Read More »

Health Care M&A Spending Grows In Q2 2013, Compared With Q1 2013, According To Irving Levin Associates, Inc.

Staff Writer | Irving Levin Associates. Inc. | July 29, 2013

Health care merger and acquisition activity strengthened in the second quarter of 2013. Deal volume was up 10% versus the previous quarter, with 223 deals announced. However, the quarter underperformed (-15%) in comparison with the same quarter a year ago, according to The Health Care M&A Report. [...] Read More »

Health Committee: Hidden Trial Data Should Be Opened Up

Maeve McClenaghan | The Bureau of Investigative Journalism (BiJ) | January 16, 2013

The pharmaceutical industry should introduce a new code of practice, ensuring negative trial data cannot be hidden, according to the government’s Health Committee. Read More »

Health Records Of Every NHS Patient To Be Shared In Vast Database

Sarah Knapton | The Telegraph | January 10, 2014

The health records of everyone in the NHS will be pooled in a vast database which can be accessed by researchers and pharmaceutical companies. But campaigners warn it could breach privacy. Read More »

Heart Failure Breakthrough May Come From "Open Source" Cancer Drug Development: Discoveries

Brie Zeltner | Cleveland.com | August 19, 2013

A newly-discovered cancer drug may be a breakthrough in treating heart failure, thanks to a groundbreaking “open source” approach to drug discovery that allowed a Case Western Reserve University heart specialist free access to the compound for his research. Read More »

Heroin Taking Oxy's Place For More Addicts

Nicole Brochu | Sun Sentinel | February 19, 2013

The state's war on pill mills is making an impact, but there's a troubling byproduct: a surge in the number of people now hooked on heroin. Read More »

How Cloud-Based Tools Can Help With FDA Compliance

Sunil Gupta | Life Science Reader | September 5, 2013

These days, enforcing FDA compliance and mentoring new team members are more challenging than ever, thanks to a workforce that is more remote, international, and diverse. [...] With these changes, pharmaceutical companies need to adapt to grow and ride the cost-conscious trend just to survive... Read More »

How the American Health Care Business Turned Patients into Consumers

A clash of cultures is rapidly developing among those of us who see the mission of the health care system to be primarily the diagnosis and healing of illness and those who see it primarily as an opportunity to create personal wealth. The concept of health care primarily as a business is uniquely American, and it has gained ascendancy during the last few decades. While there have always been a few greedy doctors, businessmen-wealth-seekers — not doctors — now dominate the medical-industrial complex. 

Read More »

IBM's Reinvention Should Inspire Flat Pharma Businesses

Dave Chase | Forbes | July 28, 2012

The pharmaceutical giants look remarkably similar to the IBM of the late 80′s and early 90′s. For those of us who remember the IBM of that era, this is bad news. Read More »

Indian Healthcare Industry Prescribing A Dose Of Technology

Ayushman Baruah | InformationWeek | October 22, 2012

Max Healthcare which has been at the forefront of delivering healthcare services in Delhi-NCR has moved to an Electronic Health Records (EHR) system from their existing Hospital Information System (HIS). The group implemented an open source EHR system, WorldVistA, with the goals of minimizing the need for paper records, allowing order entry by the doctors in the system itself, and enabling easy access to patient records. The system was hosted on a private cloud and was interfaced with laboratory, radiology and pharmacy to allow real-time access to any patient record.

Read More »

Intuitive Surgical Claims More Than 50% Savings Using Open Source EDC ClinCapture

Press Release | Clinovo, ClinCapture, Intuitive Surgical | October 23, 2013

Mark Burns, Clinical Data Manager at California-based medical device company Intuitive Surgical, cite accelerated study start-up time, autonomy, and significant cost-savings as key benefits of open source Electronic Data Capture (EDC) system ClinCapture. In a 5-min interview, Mark Burns explains how Intuitive Surgical ran over 15 post-market approval studies for Intuitive Surgical’s Da Vinci® Surgical System on Clinovo’s EDC system. Intuitive Surgical’s surgical system is installed in more than 2,025 academic and community hospital sites. The video interview features in ‘Inside ClinCapture’, a series of videos highlighting the team and customers behind ClinCapture.

Read More »

Is Big Pharma Standing In The Way Of Curing The New SARS?

Alexander Abad-Santos | Nextgov | May 30, 2013

Middle East Respiratory Symptom coronavirus (MERS-CoV), better known as the new SARS cousin that is efficiently killing people in Saudi Arabia, has been described by the World Health Organization as "a threat to the entire world." Read More »

Is Big Pharma Standing In The Way Of Curing The New SARS?

Alexander Abad-Santos | Atlantic Wire | May 29, 2013

Middle East Respiratory Symptom coronavirus (MERS-CoV), better known as the new SARS cousin that is efficiently killing people in Saudi Arabia, has been described by the World Health Organization as "a threat to the entire world."... Read More »

Is Shkreli the Exception, or the Norm, in Big Pharma?

I didn't want to write about pharmaceutical companies.  They get enough bad press, and adding to it almost seems like piling on.  If Valeant is the poster company for outrage about drug pricing, it's less because what they are doing is unusual than it is because we suspect they are the norm. Honestly, I wanted to discuss McDonald's turning their Happy Meals boxes into VR headsets --I'm not making that up -- but, gosh darn it, it's almost like the pharmaceutical companies are daring me to talk about them.  So I will.

Read More »

Is The Global Fund Heading Backwards On Access To Medicines?

Suerie Moon | PLOS.org | December 1, 2013

For nearly a decade, a bright spot on World AIDS Day has been steady growth in the number of people in developing countries accessing lifesaving HIV treatment [...]. But this year, Board discussions at the Global Fund to Fight AIDS, Tuberculosis and Malaria have set off alarm bells about a potential retreat from [...] policies that enabled such progress. Read More »